32.6 C
Vientiane
Saturday, July 12, 2025
spot_img
Home Blog Page 278

SMART launches new research group WISDOM to pioneer technologies that will help machines “see” like humans

  • Multi-million-dollar, three-and-a-half-year programme to advance Singapore’s optoelectronics and photonics capabilities and semiconductor industry, which generated over S$133 billion in 2023 and accounts for approximately 7% of Singapore’s GDP
  • Bringing together over 20 Singapore and US-based researchers, this is the first time a programme will study the combination of three integral components: optics, optoelectronics and electronics
  • WISDOM supports Singapore’s Future of Microelectronics (FME) national initiative, and has key partnerships with leading research institutions including the National Semiconductor Translation and Innovation Centre (NSTIC)
  • The IRG’s research endeavours are expected to benefit industries such as automotive, consumer electronics, healthcare, and space travel and sample collection – including applications in autonomous driving, augmented reality, robotics and high-speed data communication

SINGAPORE – Media OutReach Newswire – 7 May 2025 – Imagine creating 3D-sensing technologies so lightweight, compact and high-performance that they could take us to planets beyond Mars. The Singapore-MIT Alliance for Research and Technology (SMART), Massachusetts Institute of Technology’s (MIT) research enterprise in Singapore, has launched a new interdisciplinary research group (IRG) focused on developing next-generation 3D-sensing technologies for practical use across industries such as automotive, consumer electronics, aerospace and healthcare, among others.

Wafer-scale Integrated Sensing Devices based on Optoelectronic Metasurfaces (WISDOM)
Wafer-scale Integrated Sensing Devices based on Optoelectronic Metasurfaces (WISDOM)

Jointly led by faculty from MIT and Nanyang Technological University, Singapore (NTU Singapore), the Wafer-scale Integrated Sensing Devices based on Optoelectronic Metasurfaces (WISDOM) IRG will focus on developing ultra-thin, scalable sensing devices – systems that allow machines such as autonomous vehicles and robots to perceive depth, shape and spatial detail safely and with more versatility, much like human vision.

3-Dimensional (3D) sensing is essential for many modern applications, from autonomous vehicles and robotics to augmented reality and medical diagnostics. However, current systems still fall short of human-like perception capabilities, which pose limitations such as contextual unawareness and decision errors.

Today’s optical systems are also often bulky, expensive and difficult to mass-produce due to reliance on complex components and manual assembly. While new materials called optoelectronic metasurfaces — which are ultra-thin and can control light in powerful new ways — show great potential, it has been difficult so far to turn them into practical, widely used products, due to challenges in how these materials are combined with other technologies and manufactured at large scale.

To solve the challenges, WISDOM aims to develop compact solutions that are high performance, and enable optoelectronic metasurfaces to be manufactured using standard semiconductor processes and ready for mass-market adoption.

SMART WISDOM will be helmed by Co-Lead Principal Investigators Prof Juejun Hu, Professor of Materials Science and Engineering at MIT, and Prof Tan Chuan-Seng, Professor of Electronic Engineering at the School of Electrical and Electronic Engineering at NTU Singapore.

“What makes me really excited about WISDOM is that we’re putting together pieces that haven’t been combined before – to benefit a ton of industries and use cases. For example, think how a super light and powerful LiDAR system could make trips to planets beyond Mars a reality. It’s like having a whole new set of eyes for exploration, and about making the seemingly impossible, possible,” said Prof Juejun Hu, Co-Lead Principal Investigator, WISDOM.

Combining expertise from five leading institutions
SMART brings together top researchers from leading institutions in the United States and Singapore, including MIT, NTU Singapore, National University of Singapore (NUS), Stanford University and University of Illinois Urbana-Champaign (UIUC), to redefine how optical metasurfaces are designed, integrated and manufactured.

This multi-million, multi-year effort, supported by the National Research Foundation (NRF) Singapore under its Campus for Research Excellence and Technological Enterprise (CREATE) programme, brings together leading experts across disciplines in photonics, materials science and semiconductor engineering to position Singapore at the forefront of global innovation in sensing technologies and advanced manufacturing.

World-first approach to pioneering 3D-sensing and next-generation applications
WISDOM will capitalise on wafer-scale integration using standard silicon complementary metal-oxide-semiconductor (CMOS) processes to revolutionise how meta-optical systems are produced. This is the first time a programme is put together to study the combination of these three separate elements: optical metasurfaces, optoelectronic devices with a focus on light-emitting diodes (LEDs) and vertical surface emitting laser arrays (VCSELs); and silicon CMOS electronics.

At the heart of WISDOM’s pioneering research is their world-first approach that integrates the three elements into a wafer-scale platform. This tri-element integration seeks to unlock entirely new functionalities in optical metasurface technology, enabling next-generation sensing systems with multi-modal illumination and detection, advanced displays with built-in high-speed communication, and biomedical devices with versatile light sources for diagnostics and therapeutics.

WISDOM’s work to bridge these complementary technologies will pioneer a new frontier in integrated optoelectronics, creating solutions that were previously unattainable with conventional approaches.

“The launch of WISDOM marks an exciting chapter in SMART’s and MIT’s long legacy in Singapore – bringing together the best in their fields from US, Singapore and the region for interdisciplinary research and collaboration to drive world-class research and innovation with commercial and societal impact for Singapore and beyond. The first-of-its-kind research will pioneer groundbreaking advancements for next-generation sensing systems, enabling transformative solutions across industries such as automotive, healthcare, aerospace and consumer electronics,” said Bruce Tidor, Chief Executive Officer and Director (Interim), SMART.

WISDOM’s inaugural project aims to develop a high-performance, metasurface-enabled LiDAR prototype, addressing key challenges in scalability, integration and performance. By combining metasurface optics, optoelectronic devices, and CMOS electronics on a single silicon substrate, WISDOM seeks to redefine the capabilities of LiDAR systems. This innovation promises to enhance detection accuracy, extend range and field-of-view, and reduce motion artifacts, with transformative implications for industries such as automotive, healthcare, robotics and unmanned aerial vehicles (UAVs). Beyond improving safety in autonomous vehicles and navigation in drones, it also opens doors to revolutionary applications like glasses-free 3D displays and high-speed optical communication, laying the groundwork for smarter, more efficient technologies that will shape the future.

“WISDOM represents a paradigm shift in how meta-optical systems are integrated from discrete assembly to wafer-scale packaging. Even at the research stage, we have a clear objective to bring our innovations to market and societal impact – enabling transformative sensing technologies for mass-market applications. WISDOM is designed to streamline manufacturing by eliminating costly and intricate die-to-die assembly, significantly improving throughput,” said MIT Prof Hu Juejun.

“By combining NTU’s two decades of expertise in electronics engineering and wafer packaging with MIT’s strengths in optical systems, we aim to create a new platform for large-scale manufacturing of optical metasurfaces using industry-standard CMOS processes. NTU is known for translating fundamental research into real-world technologies, and this collaboration builds on that strength. Ranked top in the world for Electrical and Electronic Engineering1, we are well-placed to deliver innovations that are both scalable and commercially viable, while also training the next generation of engineers to lead in areas like Augmented Reality, robotics and consumer technology,” said NTU Prof Tan Chuan-Seng.

As MIT’s research enterprise in Singapore, SMART is dedicated to driving innovation that powers future industries and transforms global technological landscapes. WISDOM adds on to SMART’s continuing commitment to advancing cutting-edge and translational research in fields such as artificial intelligence, agriculture, antimicrobial resistance, cell therapy and more. In addition to advancing scientific understanding, the IRG’s work is expected to contribute to intellectual property development, technology licensing, and the creation of Singapore research spin-offs and startups in related industries.

Hashtag: #SMART

The issuer is solely responsible for the content of this announcement.

About Wafer-scale Integrated Sensing Devices based on Optoelectronic Metasurfaces (WISDOM)

WISDOM is an interdisciplinary research group (IRG) launched in April 2025 by SMART, MIT’s research enterprise in Singapore. WISDOM is the first research and industry endeavour to study and integrate optical metasurfaces, light emitting diodes (LEDs) and vertical surface emitting laser arrays (VCSELs), and complementary metal-oxide semiconductor (CMOS) electronics for industry and commercial application. By developing innovative 3D-sensing technologies that enhance system performance, scalability and cost efficiency, WISDOM aims to revolutionise optoelectronics and photonics, and address key challenges in semiconductor manufacturing and other key industries. These 3D-sensing technologies will deliver impactful advancements that drive progress in sensor innovation while fostering opportunities for commercial applications and societal benefits in Singapore and globally.

About Singapore-MIT Alliance for Research and Technology (SMART) [新加坡-麻省理工学院科研中心]

Singapore-MIT Alliance for Research and Technology () is MIT’s Research Enterprise in Singapore, established by the Massachusetts Institute of Technology (MIT) in partnership with the National Research Foundation of Singapore (NRF) since 2007. SMART is the first entity in the Campus for Research Excellence and Technological Enterprise () developed by NRF. SMART serves as an intellectual and innovation hub for research interactions between MIT and Singapore. Cutting-edge research projects in areas of interest to both Singapore and MIT are undertaken at SMART. SMART currently comprises an and five Interdisciplinary Research Groups (IRGs): Antimicrobial Resistance (), Critical Analytics for Manufacturing Personalized-Medicine (), Disruptive & Sustainable Technologies for Agricultural Precision (), Mens, Manus and Machina (), and Wafer-scale Integrated Sensing Devices based on Optoelectronic Metasurfaces (WISDOM).

SMART research is funded by the National Research Foundation Singapore under the CREATE programme.

For more information, please visit

India Launches Strikes on Pakistan, Islamabad Vows to ‘Settle the Score’

India Launches Strikes on Pakistan, Islamabad Vows to ‘Settle the Score’
Indian security personnel stand guard in Wuyan near Indian-administered Kashmir's main city of Srinagar on 7 May, 2025. (Photo by TAUSEEF MUSTAFA / AFP)

Flagship Pioneering, the National University of Singapore, National University Hospital and the National University Health System Announce Collaboration to Advance Biotech Research & Development

Collaboration Aims to Expand Globally Connected Scientific Dialogue and Accelerate Innovation in Human Health and Sustainability

SINGAPORE, May 7, 2025 /PRNewswire/ — Flagship Pioneering, the bioplatform innovation company, the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), National University Hospital (NUH) and the National University Health System (NUHS) today announced a research and development collaboration to advance outcomes in human health and sustainability. Flagship, NUS Medicine, NUH and NUHS outlined the goals of their collaboration via a Memorandum of Understanding (MOU) signed this week.

Flagship, NUS Medicine, NUH and NUHS expect to create, co-develop and co-resource a series of research projects over an initial five-year horizon, tapping into opportunities across Flagship’s existing ecosystem of over 40 companies, and future companies founded by Flagship. Through potential secondments, internships and participation in the Flagship Fellowship program, the collaboration will also create career development and mentorship opportunities for scientists and students of NUS Medicine with Flagship.

In addition, Flagship will tap into the ecosystem of NUH and NUHS to leverage clinical data for new biological insights, test clinical hypotheses for novel impact and improved patient outcomes.  

“Our collaboration with NUS Medicine, NUH and NUHS will help us realize our goal to expand the global reach and impact of Flagship and its companies and serve as an anchor in Singapore and throughout Asia Pacific for globally connected life science innovation,” said André Andonian, Chair of Asia Pacific and Strategic Advisor, Flagship Pioneering. “We are pleased to combine Flagship’s signature approach to company creation and development with the scientific expertise, data reach and translational potential of NUS Medicine, NUH and NUHS. Along with our previously announced collaboration with the Agency for Science, Technology and Research (A*STAR), our work with NUS Medicine, NUH and NUHS has the potential to bring together key players across Singapore’s biotech ecosystem to advance breakthroughs that impact patients and the planet.”

“As integral parts of the NUHS academic health system, NUS Medicine and NUH are uniquely positioned to translate groundbreaking biomedical research seamlessly into real-world clinical solutions,” said Professor Chong Yap Seng, Dean, NUS Medicine, and Deputy Chief Executive (Education & Research), NUHS. “Through this partnership with Flagship, we aim to drive greater innovation and bridge the gap between discovery and patient care. Together, we can shape a future where practice-changing innovations and transformative health solutions can benefit patients, communities and the world.”

About Flagship Pioneering

Flagship Pioneering invents and builds bioplatform companies, each with the potential for multiple products that transform human health or sustainability. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures, resulting in more than $60 billion in aggregate value. Flagship is operating with $14 billion of assets under management as of its latest capital raise, announced in July 2024. The current Flagship ecosystem comprises over 40 companies, including Foghorn Therapeutics (NASDAQ: FHTX), Moderna (NASDAQ: MRNA), Sana Biotechnology (NASDAQ: SANA), Generate BiomedicinesInariIndigo Agriculture, Lila Sciences, and Tessera Therapeutics.

About National University of Singapore (NUS)

The National University of Singapore (NUS) is Singapore’s flagship university, which offers a global approach to education, research, and entrepreneurship, with a focus on Asian perspectives and expertise. NUS has 16 colleges, faculties, and schools across three campuses in Singapore, with more than 40,000 students from 100 countries enriching its vibrant and diverse campus community. NUS has also established more than 20 NUS Overseas Colleges entrepreneurial hubs around the world.

NUS’s multidisciplinary and real-world approach to education, research and entrepreneurship enables it to work closely with industry, governments, and academia to address crucial and complex issues relevant to Asia and the world. Researchers in its faculties, research centres of excellence, corporate labs and more than 30 university-level research institutes focus on themes that include energy; environmental and urban sustainability; treatment and prevention of diseases; active ageing; advanced materials; risk management and resilience of financial systems; Asian studies; and Smart Nation capabilities such as artificial intelligence, data science, operations research, and cybersecurity.

For more information on NUS, please visit http://www.nus.edu.sg/

About the NUS Yong Loo Lin School of Medicine (NUS Medicine)

The NUS Yong Loo Lin School of Medicine is Singapore’s first and largest medical school. Its enduring mission centres on nurturing highly competent, values-driven, and inspired healthcare professionals to transform the practice of medicine and improve health around the world.

Through a dynamic and future-oriented five-year curriculum that is inter-disciplinary and inter-professional in nature, NUS Medicine students undergo a holistic learning experience that exposes them to multiple facets of healthcare and prepares them to become visionary leaders and compassionate doctors and nurses of tomorrow. Since the School’s founding in 1905, more than 12,000 graduates have passed through its doors.

In pursuit of health for all, NUS Medicine’s strategic research programmes focus on innovative, cutting-edge biomedical research with collaborators around the world to deliver high impact solutions to benefit human lives.

The School is the oldest institution of higher learning in the National University of Singapore and a founding institutional member of the National University Health System. It is one of the leading medical schools in Asia and ranks among the best in the world (Times Higher Education World University Rankings 2025 by subject and the Quacquarelli Symonds (QS) World University Rankings by subject 2024).

For more information about NUS Medicine, please visit https://medicine.nus.edu.sg/

About the National University Hospital 

The National University Hospital (NUH) is Singapore’s leading university hospital. While the hospital at Kent Ridge first received its patients on 24 June 1985, our legacy started from 1905, the date of the founding of what is today the NUS Yong Loo Lin School of Medicine. NUH is the principal teaching hospital of the medical school.

Our unique identity as a university hospital is a key attraction for healthcare professionals who aspire to do more than practise tertiary medical care. We offer an environment where research and teaching are an integral part of medicine, and continue to shape medicine and transform care for the community we care for.

We are an academic medical centre with over 1,200 beds, serving more than one million patients a year with over 50 medical, surgical and dental specialties. NUH is the only public and not-for-profit hospital in Singapore to provide trusted care for adults, women and children under one roof, including the only paediatric kidney and liver transplant programme in the country.

The NUH is a key member of the National University Health System (NUHS), one of three public healthcare clusters in Singapore.

About the National University Health System

The National University Health System (NUHS) aims to transform how illness is prevented and managed by discovering causes of disease, development of more effective treatments through collaborative multidisciplinary research and clinical trials, and creation of better technologies and care delivery systems in partnership with others who share the same values and vision.

Institutions in the NUHS Group include the National University Hospital, Ng Teng Fong General Hospital, Jurong Community Hospital, Alexandra Hospital and the upcoming Tengah General and Community Hospital; three National Specialty Centres – National University Cancer Institute, Singapore (NCIS), National University Heart Centre, Singapore (NUHCS) and National University Centre for Oral Health, Singapore (NUCOHS); the National University Polyclinics (NUP); Jurong Medical Centre; and three NUS health sciences schools – NUS Yong Loo Lin School of Medicine (including the Alice Lee Centre for Nursing Studies), NUS Faculty of Dentistry and NUS Saw Swee Hock School of Public Health.

With member institutions under a common governance structure, NUHS creates synergies for the advancement of health by integrating patient care, health science education and biomedical research. As a Regional Health System, NUHS works closely with health and social care partners across Singapore to develop and implement programmes that contribute to a healthy and engaged population in the Western part of Singapore.

For more information, please visit www.nuhs.edu.sg.

Media Contacts:

Flagship Pioneering
press@flagshippioneering.com  

NUHS/NUH
Joan Chew
Email: joan_chew@nuhs.edu.sg  

NUS Yong Loo Lin School of Medicine
Sally Toh
Email: sally.toh@nus.edu.sg  

HIGHLY Showcases Next-Gen Lightweight Thermal Management Solutions at Auto Shanghai 2025

SHANGHAI, May 7, 2025 /PRNewswire/ — At the Auto Shanghai 2025, HIGHLY (Shanghai Highly Group Co., Ltd.), a global leader in new energy vehicle (NEV) thermal management systems, unveiled its breakthrough lightweight, integrated solutions tailored for next-generation electric vehicles. The highlights include the R290 Refrigerant Thermal Management ModuleLow-Temperature Heat Pump Self-Heating Compressor, and Low-Temperature Heat Pump Integrated Compressor, reinforcing HIGHLY’s technological leadership in eco-friendly, high-efficiency automotive thermal management.

R290 Refrigerant Module: Compact, Green, and Safer
Designed to meet stringent global environmental standards, the R290 module uses natural propane refrigerant (GWP≈3), reducing carbon footprint while ensuring safety with a sub-150g charge. Through structural optimization and integrated casting, the module cuts volume and weight by 10% versus predecessors. Its ultra-thin flow channel plates (10.5mm average thickness) and embedded control systems enhance space efficiency and energy management.

Cold-Climate Innovation: Dual Compressor Solutions
Addressing extreme cold challenges, HIGHLY launched two compressor breakthroughs:

  1. Self-Heating Compressor: Enables reliable operation at -40°C via optimized motor heating and anti-liquid impact design, extending lifespan by 10%.
  2. Integrated Compressor: Combines self-heating with a printed heating membrane for rapid warming, achieving 15% weight reduction and full-scenario thermal efficiency. Both solutions overcome traditional -10°C heating limits, ensuring NEV performance in harsh environments.

Accelerating NEV Market Leadership
With China’s NEV sales hitting 12.87 million units in 2024 (35.5% YoY growth), HIGHLY is expanding its global footprint across 24 plants and 6 R&D centers in 11 countries. Its new Wuhu production line, operational since 2024, leverages smart manufacturing to meet soaring demand, aligning with industry trends toward sustainability and integration.

HIGHLY’s innovations underscore its commitment to driving the EV revolution through cutting-edge thermal management technologies, supporting global automakers in achieving energy efficiency, safety, and carbon neutrality goals.

Bee Choo Origin Strengthens CSR Efforts with Electric Van Donation to NKF


SINGAPORE – Media OutReach Newswire – 7 May 2025 – Bee Choo Origin, Singapore’s leading herbal hair care brand that specialises in hair fall treatment and oily scalp treatment, has reaffirmed its commitment to corporate social responsibility (CSR) with the donation of an electric passenger van to The National Kidney Foundation (NKF). This marks a significant step in enhancing patient mobility while promoting sustainable transport solutions.

Bee Choo Origin Strengthens CSR Efforts with Electric Van Donation to NKF
Bee Choo Origin Strengthens CSR Efforts with Electric Van Donation to NKF

This donation is part of the long tradition of Bee Choo Origin supporting NKF, reflecting its dedication to making a positive impact beyond the beauty industry. The electric van, which is the first of its kind in NKF’s fleet, will be used to provide transportation for kidney patients who require regular dialysis treatments but face difficulties commuting to and from medical centres.

Providing Safe and Eco-Friendly Transport for Kidney Patients
The donation from Bee Choo Origin supports NKF’s Wheeling for Love & Hope Programme, which provides free transport services to patients struggling with mobility issues. The new electric van is designed with built-in access steps and spacious seating, ensuring safe and comfortable travel for patients. It is expected to facilitate up to 1,044 trips annually, benefiting approximately 72 patients per week.

For many kidney patients, travelling to dialysis centres three times a week can be physically demanding and financially burdensome. NKF’s transport programme alleviates this challenge, offering patients reliable and accessible transportation at no cost. The introduction of an electric van further enhances this initiative by reducing carbon emissions and lowering operational costs in the long run.

“We’re deeply honoured to partner with NKF on this meaningful initiative,” said Ms. Lim Xue Ting, General Manager of Bee Choo Origin. “Dialysis is a lifeline for many, and we hope this contribution helps ease the journey for patients while also supporting a greener, more sustainable future. At Bee Choo Origin, community care and environmental responsibility are values we hold close, and this donation is a reflection of our ongoing commitment to both.”

Bee Choo Origin: A Legacy of Giving Back
Bee Choo Origin has been a steadfast supporter of NKF for several years, previously donating five dialysis machines since 2018 to enhance treatment capacity. The latest contribution of an electric van builds upon this partnership, reinforcing the brand’s dedication to social good.

Beyond its work with NKF, Bee Choo Origin has actively supported various charitable organisations through its CSR initiatives, including:

  • Cerebral Palsy Alliance Singapore (CPAS) – Through their partnership with the Goodwill, Rehabilitation & Occupational Workshop (GROW), Bee Choo Origin contributes to empowering individuals with cerebral palsy by supporting initiatives that promote meaningful employment, skills development, and greater independence.
  • Metta Welfare Association – Bee Choo Origin supports Metta’s programmes and the Maitri School, which focuses on uplifting individuals with special needs through tailored education, dedicated care, and inclusive community engagement.
  • A Packet of Rice – By sponsoring meals, Bee Choo Origin helps provide essential nourishment to underprivileged individuals and families across Singapore, contributing to food security and community welfare.

In 2019, the brand’s founder, Mdm Cheah Bee Chew, personally donated $150,000 from the sales proceeds of her biography to multiple social causes, demonstrating her deep-rooted belief in philanthropy.

A Commitment to Sustainability and Future CSR Initiatives
As Bee Choo Origin celebrates its 25th anniversary, the brand is looking ahead to more initiatives that align with both environmental responsibility and community welfare. The transition to electric transport solutions is a step towards reducing carbon footprints while improving the quality of life for those in need.

“We believe that businesses have a responsibility to contribute to society in meaningful ways,” added Ms. Lim Xue Ting. “Every act of kindness, no matter how small, can make a difference. We hope our contributions inspire other companies and individuals to support those in need.”

Moving forward, the brand’s CSR efforts will continue to focus on improving lives and giving back to the community. Plans are already underway for future community initiatives, reinforcing the brand’s mission of creating lasting positive change.Hashtag: #BeeChooOrigin


The issuer is solely responsible for the content of this announcement.

About Bee Choo Origin

Founded in 2000, Bee Choo Origin is Singapore’s leading hair care brand, specialising in natural, chemical-free herbal hair treatment for hair loss and scalp health. With a commitment to quality and innovation, Bee Choo Origin has expanded globally, offering effective treatments backed by traditional Chinese herbs and modern science. Beyond hair care, the brand actively supports community initiatives, including healthcare and sustainability efforts, reinforcing its dedication to making a positive impact in both beauty and society.

Britishpedia Honours Family Podiatry Centre Founder, Mark Reyneker, As a Success Icon

SINGAPORE, May 7, 2025 /PRNewswire/ — Mark Reyneker, founder of the Family Podiatry Centre, will be featured in the 7th Edition of Britishpedia’s “Successful People in Malaysia and Singapore.” He has been recognised for his significant contributions to podiatry in Singapore and Malaysia, highlighting his dedication to innovation, patient care, and the advancement of the field in the region.

Under Reyneker’s leadership, the Family Podiatry Centre has consistently been at the forefront of podiatry development. As a pioneer in the field, Reyneker founded one of the first private podiatry practices in Singapore, played a key role in establishing Malaysia’s first fully fledged podiatry centre, and was an early adopter of cutting-edge technologies such as CAD/CAM custom-made orthotics and shockwave therapy. Reyneker’s dedication to innovation is further exemplified by his patented orthotic device, which has revolutionised treatment options for various foot conditions.

Catering to patients as young as six months and as old as 99 years, Family Podiatry Centre lives up to its name by addressing foot and leg conditions across all age groups. From ingrown toenail treatment to shin splints and corn removal, the clinic has cemented its reputation for providing effective, evidence-based solutions for diverse podiatric needs.

Reyneker’s recent research as part of his Master’s degree has further cemented his reputation as a thought leader in the field. His groundbreaking study revealed that human gait is variable rather than fixed, a discovery based on the analysis of Jomon-era fossils and later Stone Age remains. His colleague at Family Podiatry Centre, Kardem, also earned a Master’s in gait analysis, adding depth to the clinic’s expertise in understanding and treating biomechanical issues.

This recognition by Britishpedia is a testament to Reyneker’s long-standing dedication to elevating podiatry in the region, ensuring that Family Podiatry Centre remains a trusted destination for those seeking a skilled podiatrist in Singapore and exceptional care.

For further information or inquiries, please visit https://familypodiatrycentre.com/.

CreateAI Releases White Paper on how AI Transforms Animation Production

BEIJING, May 7, 2025 /PRNewswire/ — CreateAI Holdings Inc. (OTCMKTS: TSPH) (“CreateAI” or the “Company”), a global artificial intelligence technology company, today announced the release of its “White Paper on the Application and Development of Multimodal Generative Technology in Animation Production” (“White Paper”). The White Paper provides a comprehensive analysis of 2D and 3D animation production workflow, detailing the transformative impact of multimodal generative technology across critical stages, including scriptwriting, storyboarding, and asset creation for the animation industry.

CreateAI Releases White Paper on how AI Transforms Animation Production
CreateAI Releases White Paper on how AI Transforms Animation Production

The White Paper also highlights the global success of Ne Zha 2, a Chinese animated film that grossed over USD $2 billion, securing its place among the top five highest-grossing films in history globally and a breakthrough for Asia-origin studio work. As the first regional film to achieve this milestone, Ne Zha 2 leveraged cutting-edge AI generative tools to enhance animation quality, streamline production, and achieve widespread critical and commercial acclaim. The paper uses this landmark project as a case study, supported by robust data, to illustrate how AI drives cost-efficiency and creative innovation in the animation industry.

A key highlight of the White Paper is the introduction of CreateAI’s Video Model Evaluation System, the industry’s first standardized framework designed specifically for animation. This system establishes benchmarks for video generation across six essential dimensions, setting a new standard for quality and consistency in AI-driven animation.

“Technological progress must be anchored in real-world applications and sustainable business models,” said Cheng Lu, President and CEO of CreateAI. “The future of digital entertainment will be shaped not by generic large-scale models but by specialized solutions tailored to specific industry needs. CreateAI is dedicated to solving animation industry challenges, redefining creative workflows, and empowering artists to amplify – not replace – their vision through AI.”

Meeting Demand for Specialized Animation Tools

Despite rapid advancements in video generation models, generic tools often fall short of the animation industry’s need for precision, stylization, and seamless workflow integration. According to the Digital Content Association of Japan’s latest report, while global video model inference speeds have improved by 120%, creator satisfaction in animation applications remains below 31%. CreateAI addresses this gap with targeted, high-performance solutions.

Deep Strategic Deployment via Application

CreateAI has established a cohesive ecosystem integrating technology, tools, and content:

  • Technology: In December 2024, CreateAI unveiled Ruyi, a proprietary text-to-video model trained on specialized animation and sci-fi datasets. Ruyi addresses challenges like frame consistency and style adaptation, delivering dependable, high-quality outputs for creators.
  • Tools: CreateAI launched the world’s-first AI video generation platform tailored for anime, comics, and gaming (ACG) content – Animon.ai – developed with top Japanese animation teams. Offered via subscription, it supports unlimited high-quality video creation.
  • IP Ecosystem: CreateAI secured exclusive adaptation rights for Louis Cha’s “Heroes of Jin Yong” and The Three-Body Problem, iconic IPs with global cultural impact and loyal fanbases, driving significant market growth potential.

The full White Paper is available for free to download at https://d7bqhtsd96p14.cloudfront.net/upload/2025050612004141l72u.pdf

Simultaneous to the White Paper release, CreateAI hosted an investor event. To watch the speech during the event by Cheng Lu, President and CEO of CreateAI, please visit: https://youtu.be/87LUpHAWmAQ

About CreateAI

CreateAI (formerly TuSimple) is a global applied artificial intelligence company with offices in the US, China, and Japan. The Company has developed leading AI technology for a number of end-use applications. The Company is pioneering the future of digital entertainment content production, seamlessly blending cutting-edge generative AI technology with the creativity of world-class talent. Our mission is to redefine the boundaries of what’s possible in digital storytelling by developing immersive, captivating, and visually stunning experiences that resonate with audiences on a global scale. 

CreateAI Media Contact:
Brad Burgess
ICR, LLC
Email: CreateAI.PR@icrinc.com 

Flytxt announces strategic AI collaborations across key markets to drive co-innovation and value creation

DUBAI, UAE, May 7, 2025 /PRNewswire/ — Flytxt, a pioneer in Agentic AI solutions for subscription businesses, today announced a major initiative to expand its market footprint through a series of strategic go-to-market partnerships, unveiled at the SynergyX Partnership Day event on 28th April 2025 in Dubai. These partnerships are aimed at accelerating innovation across industries including telecom, BFSI, retail, government, hospitality, and healthcare, by embedding Flytxt’s AI into new use cases and solutions tailored for specific markets.

This announcement marks the formal launch of new partnerships across Europe, Middle East and Australia, with organizations that will drive the adoption of Flytxt’s AI in both public and private sectors. The collaborations are structured around mutual value creation—Flytxt brings the AI technology, while partners develop domain-specific use cases and drive go-to-market execution.

“These partnerships represent more than market expansion—they are a collective step toward redefining the potential of our AI across industries,” said Dr. Vinod Vasudevan, CEO of Flytxt. “Together with visionary partners, we are bringing Agentic AI to the forefront, turning data into autonomous decisions and actions at scale—unlocking new possibilities and accelerating value creation.”

Backed by a Decade of Deep AI R&D

Flytxt’s AI is built to perpetually train and sustain its performance in diverse environments. Flytxt AI is the result of over a decade of research guided by IIT Delhi, India, and TNO, The Netherlands. What makes Flytxt’s AI truly distinctive is its massive training on trillions of real-world data points across markets and use cases. At its core lies Flytxt’s proprietary Federated Learning Engine, which enables this continuous learning from localised datasets while ensuring strict data privacy and compliance. This architecture empowers the AI to continuously deliver superior contextual intelligence and accurate outcomes across use cases.

“Our AI is built not just to analyse—but to reason, decide, and act,” added Dr. Vinod. “The real measure of success is how many high-stake decisions and high-value use cases it can enable and how fast. These partnerships are the perfect catalyst for scalable innovation.”

Strategic Regional Partnerships

  • Europe: Profile as a Service GmbH (PaaS) is embedding Flytxt’s AI and CVM Solutions into its Reach-Me product line. In partnership with Aduna and Deutsche Telekom, PaaS aims to connect with up to 3 billion consumers. It creates a unique profile for consumers across channels, businesses, and locations—giving consumers full control over their personal data and enabling a 100% GDPR-compliant ecosystem for safe, meaningful engagement.
  • Middle East: Gulf Investment and Development LLC, owned by HH. Al Sayyid Badar Taimur Al Said, will develop digital transformation solutions leveraging Flytxt AI for Oman’s public sector as well as supply AI solutions to BFSI vertical. D8Hub and Octans Digital will include Flytxt AI into its Technology and CX transformation solutions for multiple industry verticals.
  • Australia: ePrimus led by Dr. Ravi Bhatia (former CEO, Primus Telecom), will co-develop AI applications along with Flytxt for Australia’s Telecom, Banking and Finance, Insurance, and Utilities sectors.

These strategic alliances mark a significant step in Flytxt’s mission to scale real-world impact—enabling faster AI adoption, broader industry applicability, and sustained business value through co-innovation.

About Flytxt

Flytxt is a pioneer in delivering massively trained Agentic AI solutions that drive measurable business outcomes for subscription businesses. Its AI is powered by a proprietary Federated Learning Engine that enables massive training across markets, while ensuring data security and compliance. Headquartered in Dubai, Flytxt collaborates with over 80 enterprises in more than 50 countries. Learn more at www.flytxt.ai.

Video: https://www.youtube.com/watch?v=KpxMMYVg3kw